Geode Capital Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,249,005
Closed -$4.75M 4163
2020
Q1
$4.75M Buy
1,249,005
+79,170
+7% +$301K ﹤0.01% 2181
2019
Q4
$5.95M Buy
1,169,835
+17,043
+1% +$86.7K ﹤0.01% 2346
2019
Q3
$5.83M Buy
1,152,792
+38,490
+3% +$195K ﹤0.01% 2285
2019
Q2
$6.88M Buy
1,114,302
+117,282
+12% +$724K ﹤0.01% 2188
2019
Q1
$4.63M Buy
997,020
+53,749
+6% +$249K ﹤0.01% 2383
2018
Q4
$3.96M Buy
943,271
+99,428
+12% +$418K ﹤0.01% 2361
2018
Q3
$5.29M Buy
843,843
+113,614
+16% +$712K ﹤0.01% 2328
2018
Q2
$5.87M Buy
730,229
+109,989
+18% +$884K ﹤0.01% 2232
2018
Q1
$4.63M Buy
620,240
+13,730
+2% +$102K ﹤0.01% 2287
2017
Q4
$3.61M Buy
606,510
+3,416
+0.6% +$20.3K ﹤0.01% 2411
2017
Q3
$4.44M Sell
603,094
-57,089
-9% -$420K ﹤0.01% 2276
2017
Q2
$4.48M Buy
660,183
+21,550
+3% +$146K ﹤0.01% 2226
2017
Q1
$6.03M Buy
638,633
+47,907
+8% +$452K ﹤0.01% 1980
2016
Q4
$5.1M Buy
590,726
+126,247
+27% +$1.09M ﹤0.01% 2050
2016
Q3
$2.94M Buy
464,479
+7,204
+2% +$45.6K ﹤0.01% 2312
2016
Q2
$1.93M Buy
457,275
+8,711
+2% +$36.7K ﹤0.01% 2508
2016
Q1
$1.96K Sell
448,564
-69,200
-13% -$302 ﹤0.01% 2481
2015
Q4
$3.17M Sell
517,764
-1,947
-0.4% -$11.9K ﹤0.01% 2178
2015
Q3
$2.97M Buy
519,711
+82,627
+19% +$473K ﹤0.01% 2180
2015
Q2
$3.26M Buy
437,084
+8,094
+2% +$60.4K ﹤0.01% 2193
2015
Q1
$2.57M Buy
428,990
+1,200
+0.3% +$7.18K ﹤0.01% 2287
2014
Q4
$3.23M Buy
427,790
+8,989
+2% +$67.9K ﹤0.01% 2102
2014
Q3
$2.17M Buy
418,801
+4,472
+1% +$23.2K ﹤0.01% 2312
2014
Q2
$1.79M Buy
414,329
+1,386
+0.3% +$5.97K ﹤0.01% 2436
2014
Q1
$1.69M Buy
412,943
+115,936
+39% +$474K ﹤0.01% 2437
2013
Q4
$1.58M Buy
297,007
+34,362
+13% +$183K ﹤0.01% 2436
2013
Q3
$1.32M Buy
262,645
+56,983
+28% +$287K ﹤0.01% 2437
2013
Q2
$917K Buy
+205,662
New +$917K ﹤0.01% 2511